Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 14;398(10300):577-578.
doi: 10.1016/S0140-6736(21)01693-7. Epub 2021 Jul 27.

Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis

Prakash Bhuyan  1 , Jennie Medin  2 , Hugo Gomes da Silva  3 , Madhavi Yadavalli  4 , Nirmal Kumar Shankar  5 , Hana Mullerova  3 , Matthew Arnold  3 , Magnus Nord  6
Affiliations

Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis

Prakash Bhuyan et al. Lancet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

We are employees of AstraZeneca and might have stock or options, or both. Details of contributions are shown in the appendix.

Comment in

References

    1. Brighton Collaboration Updated Proposed Brighton Collaboration process for developing a standard case definition for study of new clinical syndrome X, as applied to Thrombosis with Thrombocytopenia Syndrome (TTS) May 18, 2021. https://brightoncollaboration.us/wp-content/uploads/2021/05/TTS-Interim-...
    1. Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. New Engl J Med. 2021;384:2092–2101. - PMC - PubMed
    1. Burn E, Li X, Kostka K, et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 20·6 million people in six European countries. medRxiv. 2021 doi: 10.1101/2021.05.12.21257083. published online May 13. (preprint). - DOI - PMC - PubMed
    1. Eslamifar Z, Behzadifard M, Soleimani M, Behzadifard S. Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor. Thromb J. 2020;18:38. - PMC - PubMed
    1. AstraZeneca Vaxzevria, COVID-19 Vaccine (ChAdOx1-S [recombinant]). Summary of Product Characteristics. June, 2021. https://www.ema.europa.eu/en/documents/product-information/vaxzevria-pre...